The Rakai Health Sciences Program (RHSP), the research entity where the first studies to establish the presence of HIV in Uganda were carried out in the 1980s was recognized for enabling adoption of new interventions such as Medical Male Circumcision and enrolling people on treatment immediately after testing positive since studies that confirmed efficacy was done there.
Initial studies had highlighted a possible link between DTG and birth defects of the brain and spinal cord, that cause conditions like spina bifida in infants born to women who used the drug at the time of conception.
